Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 27, 2017 20:09 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., July 27, 2017 -- Portola Pharmaceuticals, Inc.® (NASDAQ:PTLA) announced today that on July 25, 2017, the Compensation Committee of the Board of Directors approved, effective as of July 31,...
LogMeIn Announces Second Quarter 2017 Results
Jul 27, 2017 20:08 pm UTC| Business
BOSTON, July 27, 2017 -- LogMeIn, Inc. (NASDAQ:LOGM), a leading provider of cloud-based connectivity, today announced its results for the second quarter ended June 30, 2017. Second quarter 2017 highlights include: ...
VASCO Names Scott Clements Chief Executive Officer
Jul 27, 2017 20:07 pm UTC| Business
OAKBROOK TERRACE, Ill., and ZURICH, Switzerland, July 27, 2017 -- VASCO Data Security International, Inc. (NASDAQ:VDSI), a global leader in digital solutions including identity, security and business productivity, today...
Cerner Reports Second Quarter 2017 Results
Jul 27, 2017 20:06 pm UTC| Business
KANSAS CITY, Mo., July 27, 2017 -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2017 second quarter that ended July 1, 2017. Bookings in the second quarter of 2017 were $1.636 billion, which is an...
Ultragenyx Reports Second Quarter 2017 Financial Results and Corporate Update
Jul 27, 2017 20:06 pm UTC| Business
NOVATO, Calif., July 27, 2017 -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported its financial...
Actinium Announces Proposed Public Offering of Common Stock and Warrants to Purchase Stock
Jul 27, 2017 20:06 pm UTC| Business
NEW YORK, July 27, 2017 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment...
LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
Jul 27, 2017 20:06 pm UTC| Business
BURLINGTON, Mass., July 27, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2017 results, provided increased guidance, announced a $0.055/share...